Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Loeffler

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neuroinflammation|June 6, 2013
Intravenous immunoglobulin and Alzheimer's disease: what now?David A Loeffler
Frontiers in Neurology|June 18, 2020
AMBAR, an Encouraging Alzheimer's Trial That Raises QuestionsDavid A Loeffler
Journal of Neuroinflammation|April 17, 2015
Erratum: Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?David A Loeffler
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's DiseaseDavid A Loeffler
Journal of Alzheimer'S Disease Reports|September 4, 2023
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream EffectsDavid A Loeffler
Journal of Neuroinflammation|October 14, 2004
Using animal models to determine the significance of complement activation in Alzheimer's diseaseDavid A Loeffler
Journal of Neurochemistry|January 12, 2023
Experimental approaches for altering the expression of Abeta-degrading enzymesDavid A Loeffler
Frontiers in Aging Neuroscience|March 28, 2019
Influence of Normal Aging on Brain Autophagy: A Complex ScenarioDavid A Loeffler
Journal of Neuroinflammation|December 6, 2014
Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?David A Loeffler
Frontiers in Aging Neuroscience|June 14, 2024
Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approachesDavid A Loeffler
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neuroinflammation|June 6, 2013
Intravenous immunoglobulin and Alzheimer's disease: what now?David A Loeffler
Frontiers in Neurology|June 18, 2020
AMBAR, an Encouraging Alzheimer's Trial That Raises QuestionsDavid A Loeffler
Journal of Neuroinflammation|April 17, 2015
Erratum: Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?David A Loeffler
Journal of Alzheimer'S Disease : JAD|January 18, 2021
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's DiseaseDavid A Loeffler
Journal of Alzheimer'S Disease Reports|September 4, 2023
Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream EffectsDavid A Loeffler
Journal of Neuroinflammation|October 14, 2004
Using animal models to determine the significance of complement activation in Alzheimer's diseaseDavid A Loeffler
Journal of Neurochemistry|January 12, 2023
Experimental approaches for altering the expression of Abeta-degrading enzymesDavid A Loeffler
Frontiers in Aging Neuroscience|March 28, 2019
Influence of Normal Aging on Brain Autophagy: A Complex ScenarioDavid A Loeffler
Journal of Neuroinflammation|December 6, 2014
Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?David A Loeffler
Frontiers in Aging Neuroscience|June 14, 2024
Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approachesDavid A Loeffler
Pageof 5